(Q42119922)

16 October 2017

title

Effect of recombinant human interleukin 4 on spontaneous in vitro human IgE synthesis (English)

1 reference

16 October 2017

Yang XD

1

1 reference

16 October 2017

De Weck AL

series ordinal

2

1 reference

16 October 2017

Stadler BM

series ordinal

3

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 November 1988

1 reference

European Journal of Immunology

16 October 2017

published in

1 reference

16 October 2017

volume

18

1 reference

16 October 2017

issue

11

1 reference

16 October 2017

page(s)

1699-1704

1 reference

Induction of human in vitro IgE synthesis via stimulation by anti-CD3 antibody

16 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Human IgE synthesis in vitro. Detection with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Functional heterogeneity within the human peripheral blood B cell pool engaged in IgE synthesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Differential regulation of IgG1 and IgE synthesis by interleukin 4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Factors influencing human IgE synthesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Expression of human immune interferon cDNA in E. coli and monkey cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Role of γ-interferon in antibody-producing responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

The Cell Biology of Macrophage Activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830181107

7 January 2021

Identifiers

DOI

10.1002/EJI.1830181107

1 reference

16 October 2017

1 reference